Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tylvalosin Tartrate
2. Chembl2105658
| Molecular Weight | 1192.3 g/mol |
|---|---|
| Molecular Formula | C57H93NO25 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 26 |
| Rotatable Bond Count | 22 |
| Exact Mass | 1191.60366745 g/mol |
| Monoisotopic Mass | 1191.60366745 g/mol |
| Topological Polar Surface Area | 366 Ų |
| Heavy Atom Count | 83 |
| Formal Charge | 0 |
| Complexity | 2000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 21 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Tylvalosin Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tylvalosin Tartrate, including repackagers and relabelers. The FDA regulates Tylvalosin Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tylvalosin Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tylvalosin Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tylvalosin Tartrate supplier is an individual or a company that provides Tylvalosin Tartrate active pharmaceutical ingredient (API) or Tylvalosin Tartrate finished formulations upon request. The Tylvalosin Tartrate suppliers may include Tylvalosin Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Tylvalosin Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tylvalosin Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tylvalosin Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tylvalosin Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tylvalosin Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tylvalosin Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tylvalosin Tartrate suppliers with NDC on PharmaCompass.
Tylvalosin Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tylvalosin Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tylvalosin Tartrate GMP manufacturer or Tylvalosin Tartrate GMP API supplier for your needs.
A Tylvalosin Tartrate CoA (Certificate of Analysis) is a formal document that attests to Tylvalosin Tartrate's compliance with Tylvalosin Tartrate specifications and serves as a tool for batch-level quality control.
Tylvalosin Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Tylvalosin Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tylvalosin Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tylvalosin Tartrate EP), Tylvalosin Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tylvalosin Tartrate USP).
LOOKING FOR A SUPPLIER?
